Live Pharma Export data of Pakistan exports to united-arab-emirates under HS Code 30 via Port Karachi-airport , our Pakistan customs export data reports include date, value, quantity, product description, HS code, port, country, and Pakistan pharma exporters data
Date |
HS Code |
Product Description |
Destination Country |
Loading Port |
QTY. |
Unit |
Value($) |
Exporter Name |
|---|---|---|---|---|---|---|---|---|
|
April 18, 2024 |
30042000
|
PHARMACEUTICALS LASIX INJ. PRED FORTE DROP. AUGMENTIN BD 1000MG, DIAMICRON MR TAB, FORTUM 1G INJ .E.T.C AS PAR INVOICE AND PACKING LIST |
United Arab Emirates | KARACHI AIRPORT |
12217 |
KG |
9197.28 |
Exporter Name |
2024-04-18 14:39:19
PHARMACEUTICALS LASIX INJ. PRED FORTE DROP. AUGMENTIN BD 1000MG, DIAMICRON MR TAB, FORTUM 1G INJ .E.T.C AS PAR INVOICE AND PACKING LIST
12217
KG
9197.28
The database includes shipment-level information such as shipment date, HS code, product description, quantity, value, port details, country of origin & destination, & importer-exporter information for accurate trade analysis of products under HS code 30 for Pakistan pharma imports from Thailand via Port Karachi-airport.
Port Karachi-airport typically refers to a port that is used for handling and forwarding shipments from Pakistan, making it important for tracking inland and cross-border trade flows.
It helps businesses understand sourcing patterns, evaluate supplier performance, track pricing trends, and identify demand for pharma products, enabling better decision-making for trade and market expansion for Pakistan pharma exports from united-arab-emirates under HS code 30 via Port Karachi-airport.
Businesses can identify key importers, evaluate supplier competitiveness, track pricing trends, and analyze demand for specific rubber products to make strategic sourcing and expansion decisions.
Importers, exporters, traders, manufacturers, and market analysts can use this data to understand trade patterns, optimize supply chains, identify potential partners, and gain a competitive advantage in the pharma market.
